CANCER BUZZ PODCAST

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.

In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC about shared decision making in the management of relapsed or refractory mantle cell lymphoma.

In this episode, CANCER BUZZ speaks with Jacquelyn Doenges, LCSW, MSSW, CTTS, and Linda Hutkin-Slade, MSW, LCSW, OSW-C about providing optimal psychosocial support for this patient population.

In this episode, CANCER BUZZ speaks with Karen Fancher, PharmD, BCOP, and Victoria Nachar, PharmD, BCOP, about strategies to address common adverse events experienced by patients with mantle cell lymphoma. 

In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor at Emory University School of Medicine in Atlanta, Georgia, about fostering trust, rapport, and collaboration in the patient-provider relationship.

In this episode, CANCER BUZZ speaks with David Sallman, MD and Karley Trautman, DNP, ANP-BC, AGACNP-BC, to discuss best practices in the management of anemia in low-risk MDS patients.

Anemia presents a significant challenge in the management of patients with low-risk MDS. As clinicians focus on maintaining quality of life, it is necessary to understand the care sequencing of anemia treatment in patients with low-risk MDS.